Patent exclusivity refers to the period during which a drug manufacturer has the exclusive right to market a drug. This period typically begins when the drug is approved by the Food and Drug Administration (FDA). During this time, no other manufacturer is allowed to produce or sell generic versions of the drug. This exclusivity is crucial for the pharmaceutical company to recoup the investment made in the development of the drug.
